'No time to be lost!' Ethical considerations on consent for inclusion in emergency pharmacological research in severe traumatic brain injury in the European Union

Science and Engineering Ethics

Volumn 13, Issue 3, 2007, Pages 371-381

  Kompanje, Erwin J O ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Clinical ethics; Deferred consent; Pharmacological trial; Proxy consent; Traumatic brain injury; Waiver of consent

Indexed keywords

NEUROPROTECTIVE AGENT;

ARTICLE; BRAIN INJURY; CLINICAL TRIAL; EMERGENCY; ETHICS; EUROPEAN UNION; HUMAN; INFORMED CONSENT; LEGAL ASPECT;

BRAIN INJURIES; CLINICAL TRIALS AS TOPIC; EMERGENCIES; EUROPEAN UNION; HUMANS; INFORMED CONSENT; NEUROPROTECTIVE AGENTS;

EID: 38349194837     PISSN: 13533452     EISSN: 16605454     Source Type: Journal    
DOI: 10.1007/s11948-007-9027-4     Document Type: Article

References (47)

1. McGarry, L. J., Thompson, D., Millham, F. H., Cowell, L., Snyder, P. J., Lenderking, W. R., & Weinstein, M. C. (2002). Outcomes and costs of acute treatment of traumatic brain injury. Journal of Trauma, 53, 1152-1159.
2. Maas, A. I. R., Steyerberg, E. W., & Murray, G. D. (1999). Why have recent trials of neuroprotective agents in head injury failed to show convincing efficacy? A pragmatic analysis and theoretical considerations. Neurosurgery, 44, 1286-1298.
3. European Union (2001) Directive 2001/20/EC of the European Parliament and the Council of 4 april 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. Oficial Journal of the European Community L 121/34.
4. Kompanje, E. J. O., & Maas, A. I. R. (2004). 'Treat first, ask later?' Emergency research in acute neurology and neurotraumatology in the European Union. Intensive Care Medicine, 30, 168-169.
5. Silverman, H. J., Druml, C., Lemaire, F., & Nelson, R. (2004). The European Union directive and the protection of incapacitated subjects in research: An ethical analysis. Intensive Care Medicine, 30, 1723-1729.
6. Liddell, K., Chamberlain, D., Menon, D. K., Bion, J., Kompanje, E. J. O., Lemaire, F., Druml, C., Vrhovac, B., Widermann, C. J., & Sterz, F. (2006). The European clinical trial directive revisited: The VISEAR recommendations. Resuscitation, 69, 9-14.
7. Visser, H. K. A. (2001). Non-therapeutic research in the EU in adults incapable of giving consent? The Lancet, 357, 818-819.
8. Baeyens, A. J. (2002). Implementation of the clinical trials directive: Pitfalls and benefits. European Journal of Health Law, 9, 31-47.
9. Lemaire, F., Bion, J., Blanco, J., Damas, P., Druml, C.,& Falke, K. L. (2005). The European Union directive on clinical research: Present status of implementation in EU member states' legislation with regard to the incompetent patient. Intensive Care Medicine, 31, 476-479.
10. Stertz, F., Singer, E. A., Böttiger, B., Chamberlain, D., Baskett, P., Bossaert, L., & Steen, P. (2002). A serious threat to evidence based resuscitation within the European Union. Resuscitation, 53, 237-238.
11. Kompanje, E. J. O., Maas, A. I. R., & Dippel, D. W. J. (2003). Klinisch geneesmiddelenonderzoek bij acuut beslissingsonbekwame patiënten in de neurologie en de neurochirurgie; implicaties van nieuwe Europese regelgeving. Nederlands Tijdschrift voor Geneeskunde, 147, 1585-1589.
12. Kompanje, E. J. O., Maas, A. I. R., Hilhorst, M. T., Slieker, F. J. A., & Teasdale, G. M. (2005). Ethical considerations on consent procedures for emergency research in severe and moderate traumatic brain injury. Acta Neurochirurgica, 147, 633-640.
13. Singer, E. A., & Druml, C. (2005). Collateral damage or apocalypse now for European academic research. Intensive Care Medicine, 31, 271.
14. Lemaire, F. J. P. (2003). A European directive for clinical research. Intensive Care Medicine, 29, 1818-1820.
15. Lemaire, F. (2005). Waiving consent for emergency research. European Journal of Clinical Investigation, 35, 287-289.
16. Druml, C. (2004). Informed consent of incapable (ICU) patients in Europe: Existing laws and the EU directive. Current Opinion Critical Care, 10, 570-573.
17. Truog, R. D. (2005). Will ethical requirements bring critical care research to a halt? Intensive Care Medicine, 31, 338-344.
18. Klepsted, P., & Dale, O. (2006). Further restrictions for ICU research. Intensive Care Medicine, 32, 175.
19. Annane, D., Outlin, H., Fisch, C., & Bellissant, E. (2004). The effect of waiving consent on enrolment in a sepsis trial. Intensive Care Medicine, 30, 632-637.
20. Larsson, A., & Tønnesen, E. (2006). ICU research in Denmark: Difficult but possible. Intensive Care Medicine, 32, 934.
21. The Working Party for Implementation of Directive 2001/20/EC (2005). Clinical Research with medicinal products in the Netherlands. Ministry of Welfare and Sport.
22. Roupie, E., Santin, A., Boulme, R., Wartel, J. S., Lepage, E., Lemaire, F., Lejonc, J. L., & Montagne, O. (2000). Patients preferences concerning medical information and surrogacy: Results of a prospective study in a French emergency department. Intensive Care Medicine, 26, 52-56.
23. Coppolino, M., & Ackerson, L. (2001). Do surrogate decision makers provide accurate consent for intensive care research? Chest, 119, 603-612.
24. Sulmasy, D. P., Haller, K., & Terry, P. B. (1994). More talk, less paper: Predicting the accuracy of substituted judgments. American Journal of Medicine, 96, 432-438.
25. Ågård, A., Hermerén, G., & Herlitz, J. (2001). Patients experiences of intervention trials on the treatment of myocardial infarction: Is it time to adjust the informed consent procedure to the patients capacity? Heart, 86, 632-637.
26. Mason, S. A., & Allmark, P. J. (2000). Obtaining informed consent to neonatal randomised controlled trials: Interviews with parents and clinicians in the Euricon study. The Lancet, 356, 2045-2051.
27. Clifton, G. L., Knudson, P., & McDonald, M. (2002). Waiver of consent in studies of acute brain injury. Journal of Neurotrauma, 19, 1121-1126.
28. Wright, D. W., Lancaster, R. T., & Lowery, D. W. (2001). Necessary time to achive next of kin proxy consent for acutely injured altered status patients. Academic Emergency Medicine, 8, 419-420.
29. CRASH trial management group. (2004). Research in emergency situations: With or without relatives consent. Emergency Medicine Journal, 21, 703.
30. Luce, J. M. (2003). Is the concept of informed consent applicable to clinical research involving critically ill patients? Critical Care Medicine, 31(Suppl.), S153-S160.
31. Hsieh, M., Dailey, M. W., & Callaway, C. W. (2001). Surrogate consent by family members for out-of-hospital cardiac arrest research. Academic Emergency Medicine, 8, 851-853.
32. Bigatello, L. M., George, E., & Hurford, W. E. (2003). Ethical considerations for research in critically ill patients. Critical Care Medicine, 31, S178-S181.
33. Cuttini, M. (2000). Proxy informed consent in pediatric research: A review. Early Human Development, 60, 89-100.
34. Sugarman, J. (2000). Is the emperor really wearing new clothes? Informed consent for acute coronary syndromes. American Heart Journal, 140, 2-3.
35. Williams, B. F., French, J. K., & White, H. D. (2003). Informed consent during the clinical emergency of acute myocardial infarction (HERO-2 consent substudy): A prospective observational study. The Lancet, 361, 918-922.
36. Harth, S. C., & Thong, Y. H. (1995). Parental perceptions and attitudes about informed consent in clinical research involving children. Social Science and Medicine, 40, 1573-1577.
37. McClure, K. B., Delorio, N. M., Gunnels, M. D., Ochsner, M. J., Biros, M. H., & Schmidt, T. A. (2003). Attitudes of emergency department patients and visitors regarding emergency exception from informed consent in resuscitation research, community consultation and public notification. Academic Emergency Medicine, 10, 352-359.
38. Blixen, C. E., & Agich, G. J. (2005). Stroke patients preferences and values about emergency research. Journal of Medical Ethics, 31, 608-661.
39. Tu, J. V., Willison, D. J., Silver, F. L., Fang, J., Richards, J. A., Laupacis, A., & Kapral, M. K. (2004). Impracticability of informed consent in the registry of the Canadian stroke network. New England Journal of Medicine, 350, 1414-1421.
40. Maas, A. I. R., Murray, G., Henney, H., Kassem, N., Legrand, V., Mangelus, M., Muizelaar, J. P., Stocchetti, N., Knoller, N, on behalf of the Pharmos TBI Investigators. (2006). Efficacy and safety of dexanabinol in sever traumatic brain injury: Results of a phase III randomized placebo controlled clinical trial. The Lancet-Neurology, 5, 38-45.
41. Hoff, J. T. (1986). Cerebral protection. Journal of Neurosurgery, 65, 579-591.
42. Shohami, E. (1995). Long-term effect of HU-211, a novel competitive NMDA antagonist, on motor and memory functions after closed head injury in the rat. Brain Research, 674, 55-56.
43. Kompanje, E. J. O., Maas, A. I. R., Slieker, F. J. A., & Stocchetti, N. (2007). Ethical implications of time frames in a randomized controlled trial in severe traumatic brain injury. Progress Brain Research, 161, 237-244.
44. Kompanje, E. J. O., & Maas, A. I. R. (2006). Is the Glasgow coma scale score protected health information? The effect of new United States regulations (HIPAA) on completion of screening logs in emergency research trials. Intensive Care Medicine, 32, 313-314.
45. Freeman, D. B. (2001). Safeguarding patients in clinical trials with high mortality rates. American Journal of Critical Care Medicine, 164, 190-192.
46. Lewis, R. J., Berry, D. A., Cryer, H., Fost, N., Krome, R., Washington, G. R., Houghton, J., Blue, J. W., Bechhofer, R., Cook, T., & Fisher, M. (2001). Monitoring a clinical trial conducted under the Food and Drug Administration regulations allowing a waiver of prospective informed consent: The Diaspirin cross-linked hemoglobin traumatic hemorrhagic shock efficacy trial. Annals of Emergency Medicine, 38, 397-404.
47. Kompanje, E. J. O., Maas, A. I. R., & Slieker, F. J. A. Deferred Consent or Waiver of Consent could be the answer. Time windows and ethical implications in a multi-center clinically controlled randomized Phase III trial in acute traumatic brain injury.